259 related articles for article (PubMed ID: 20598359)
1. Renal expression of proto-oncogene Ets-1 on matrix remodeling in experimental diabetic nephropathy.
Liu DX; Liu XM; Su Y; Zhang XJ
Acta Histochem; 2011 Sep; 113(5):527-33. PubMed ID: 20598359
[TBL] [Abstract][Full Text] [Related]
2. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of C-peptide on renal morphology in diabetic rats.
Sun W; Gao X; Zhao X; Cui D; Xia Q
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
[TBL] [Abstract][Full Text] [Related]
4. Possible role of Ets-1 and MMP-1 in matrix remodeling in experimental cisplatin nephropathy.
Nazneen A; Razzaque MS; Liu D; Taguchi T
Med Electron Microsc; 2002 Dec; 35(4):242-7. PubMed ID: 12658359
[TBL] [Abstract][Full Text] [Related]
5. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
[TBL] [Abstract][Full Text] [Related]
6. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
7. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
8. Role of connective tissue growth factor in experimental radiation nephropathy in rats.
Liu DG; Wang TM
Chin Med J (Engl); 2008 Oct; 121(19):1925-31. PubMed ID: 19080126
[TBL] [Abstract][Full Text] [Related]
9. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
Dong FQ; Li H; Cai WM; Tao J; Li Q; Ruan Y; Zheng FP; Zhang Z
Chin Med J (Engl); 2004 Jul; 117(7):1040-4. PubMed ID: 15265379
[TBL] [Abstract][Full Text] [Related]
10. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
[TBL] [Abstract][Full Text] [Related]
11. [Effects of puerarin on renal function, expressions of MMP-2 and TIMP-2 in diabetic rats].
Duan HJ; Liu SX; Zhang YJ; Liu QJ; He N; Li YM
Yao Xue Xue Bao; 2004 Jul; 39(7):481-5. PubMed ID: 15493832
[TBL] [Abstract][Full Text] [Related]
12. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
[TBL] [Abstract][Full Text] [Related]
13. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.
Takamiya Y; Fukami K; Yamagishi S; Kaida Y; Nakayama Y; Obara N; Iwatani R; Ando R; Koike K; Matsui T; Nishino Y; Ueda S; Cooper ME; Okuda S
Nephrol Dial Transplant; 2013 Jan; 28(1):55-62. PubMed ID: 23028104
[TBL] [Abstract][Full Text] [Related]
14. [The role of changes of MMP-2, 9 activity in the development of liver fibrosis in rats].
Wang XB; Liu P; Tang ZP; Lu X; Liu CH; Hu YY; Xu LM; Gu HT; Liu C
Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):267-70. PubMed ID: 15161499
[TBL] [Abstract][Full Text] [Related]
15. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-9 associated with ets-1 proto-oncogene in rat tubulointerstitial cells.
Naito T; Tanihata Y; Nishimura H; Tanaka T; Higuchi C; Taguchi T; Sanaka T
Nephrol Dial Transplant; 2005 Nov; 20(11):2333-48. PubMed ID: 16046515
[TBL] [Abstract][Full Text] [Related]
17. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
[TBL] [Abstract][Full Text] [Related]
20. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
